Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
Bempedoic acid by Esperion Therapeutics for Cardiovascular Disease: Likelihood of Approval
Bempedoic acid is under clinical development by Esperion Therapeutics and currently in Phase III for Cardiovascular Disease. According to GlobalData,...
Data Insights
Bempedoic acid by Esperion Therapeutics for Hypercholesterolemia: Likelihood of Approval
Bempedoic acid is under clinical development by Esperion Therapeutics and currently in Phase II for Hypercholesterolemia. According to GlobalData, Phase...